Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II

NCT00861692 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Heparin-induced Thrombocytopenia Type II

Interventions

DRUG: argatroban

Sponsor

Tanabe Pharma Corporation